{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:35:58Z","timestamp":1793410558203,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SERB-DST India"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06588-y","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:46:12Z","timestamp":1760964372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Shashanka Shekhar","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousar","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetanshu","family":"Saproo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumojit","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Nautiyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipsita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. V.","family":"Bharatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivatsava","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"Pt 10","key":"6588_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1107\/S1399004714015788","volume":"70","author":"M Moreno-Morcillo","year":"2014","unstructured":"Moreno-Morcillo M, Taylor NM, Gruene T, Legrand P, Rashid UJ, Ruiz FM, et al. Solving the RNA polymerase I structural puzzle. Acta Crystallogr D Biol Crystallogr. 2014;70(Pt 10):2570\u201382.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"6588_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-94-007-4525-4_10","volume":"61","author":"SJ Goodfellow","year":"2013","unstructured":"Goodfellow SJ, Zomerdijk JC. Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes. Subcell Biochem. 2013;61:211\u201336.","journal-title":"Subcell Biochem"},{"issue":"1","key":"6588_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0092-8674(78)90143-5","volume":"13","author":"SA Liebhaber","year":"1978","unstructured":"Liebhaber SA, Wolf S, Schlessinger D. Differences in rRNA metabolism of primary and SV40-transformed human fibroblasts. Cell. 1978;13(1):121\u20137.","journal-title":"Cell"},{"issue":"5","key":"6588_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrc3496","volume":"13","author":"MJ Bywater","year":"2013","unstructured":"Bywater MJ, Pearson RB, McArthur GA, Hannan RD. Dysregulation of the basal RNA polymerase transcription apparatus in cancer. Nat Rev Cancer. 2013;13(5):299\u2013314.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"6588_CR5","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1158\/1078-0432.CCR-17-0282","volume":"23","author":"R Cornelison","year":"2017","unstructured":"Cornelison R, Dobbin ZC, Katre AA, Jeong DH, Zhang Y, Chen D, et al. Targeting RNA-polymerase I in both chemosensitive and chemoresistant populations in epithelial ovarian cancer. Clin Cancer Res. 2017;23(21):6529\u201340.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"6588_CR6","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","volume":"82","author":"AR Elhamamsy","year":"2022","unstructured":"Elhamamsy AR, Metge BJ, Alsheikh HA, Shevde LA, Samant RS. Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance. Cancer Res. 2022;82(13):2344\u201353.","journal-title":"Cancer Res"},{"issue":"22","key":"6588_CR7","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1111\/j.1742-4658.2010.07892.x","volume":"277","author":"I Grummt","year":"2010","unstructured":"Grummt I. Wisely chosen paths\u2013regulation of rRNA synthesis: delivered on 30 June 2010 at the 35th FEBS Congress in Gothenburg. Sweden FEBS J. 2010;277(22):4626\u201339.","journal-title":"Sweden FEBS J"},{"issue":"1","key":"6588_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","volume":"18","author":"J Pelletier","year":"2018","unstructured":"Pelletier J, Thomas G, Volarevic S. Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2018;18(1):51\u201363.","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"6588_CR9","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.3390\/cancers14235776","volume":"14","author":"S Pitts","year":"2022","unstructured":"Pitts S, Laiho M. Regulation of RNA polymerase I stability and function. Cancers (Basel). 2022;14(23):5776.","journal-title":"Cancers (Basel)."},{"issue":"Suppl 3","key":"6588_CR10","doi-asserted-by":"publisher","first-page":"S1490","DOI":"10.1245\/s10434-015-4652-7","volume":"22","author":"M Ueda","year":"2015","unstructured":"Ueda M, Iguchi T, Nambara S, Saito T, Komatsu H, Sakimura S, et al. Overexpression of transcription termination factor 1 is associated with a poor prognosis in patients with colorectal cancer. Ann Surg Oncol. 2015;22(Suppl 3):S1490\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"6588_CR11","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1016\/j.ymthe.2023.09.014","volume":"31","author":"Z Dai","year":"2023","unstructured":"Dai Z, Zhu W, Hou Y, Zhang X, Ren X, Lei K, et al. METTL5-mediated 18S rRNA m(6)A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Mol Ther. 2023;31(11):3225\u201342.","journal-title":"Mol Ther"},{"issue":"5193","key":"6588_CR12","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1126\/science.7801130","volume":"266","author":"JC Zomerdijk","year":"1994","unstructured":"Zomerdijk JC, Beckmann H, Comai L, Tjian R. Assembly of transcriptionally active RNA polymerase I initiation factor SL1 from recombinant subunits. Science. 1994;266(5193):2015\u20138.","journal-title":"Science"},{"key":"6588_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev.pharmtox.010909.105844","volume":"50","author":"D Drygin","year":"2010","unstructured":"Drygin D, Rice WG, Grummt I. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol. 2010;50:131\u201356.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"6588_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10147-023-02342-w","volume":"28","author":"C Batbayar","year":"2023","unstructured":"Batbayar C, Ishii N, Harimoto N, Yokobori T, Saito H, Gantumur D, et al. High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer. Int J Clin Oncol. 2023;28(7):901\u201312.","journal-title":"Int J Clin Oncol"},{"issue":"18","key":"6588_CR15","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1080\/15384101.2016.1215385","volume":"15","author":"S Rossetti","year":"2016","unstructured":"Rossetti S, Wierzbicki AJ, Sacchi N. Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA polymerase I transcription machinery. Cell Cycle. 2016;15(18):2515\u201326.","journal-title":"Cell Cycle"},{"issue":"2","key":"6588_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41417-022-00544-4","volume":"30","author":"S Saproo","year":"2023","unstructured":"Saproo S, Sarkar SS, Gupta E, Chattopadhyay S, Charaya A, Kalra S, et al. MiR-330-5p and miR-1270 target essential components of RNA polymerase I transcription and exhibit a novel tumor suppressor role in lung adenocarcinoma. Cancer Gene Ther. 2023;30(2):288\u2013301.","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"6588_CR17","first-page":"671","volume":"19","author":"F Yang","year":"2020","unstructured":"Yang F, Liu H, Zhao J, Ma X, Qi W. POLR1B is upregulated and promotes cell proliferation in non-small cell lung cancer. Oncol Lett. 2020;19(1):671\u201380.","journal-title":"Oncol Lett"},{"issue":"1","key":"6588_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12935-021-02237-8","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang J, Liu W, Ge R, Gao T, Tian Q, et al. UBTF facilitates melanoma progression via modulating MEK1\/2-ERK1\/2 signalling pathways by promoting GIT1 transcription. Cancer Cell Int. 2021;21(1):543.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"6588_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/cells9020266","volume":"9","author":"R Ferreira","year":"2020","unstructured":"Ferreira R, Schneekloth JS Jr, Panov KI, Hannan KM, Hannan RD. Targeting the RNA polymerase I transcription for cancer therapy comes of age. Cells. 2020;9(2):266.","journal-title":"Cells"},{"issue":"4","key":"6588_CR20","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","volume":"71","author":"D Drygin","year":"2011","unstructured":"Drygin D, Lin A, Bliesath J, Ho CB, O\u2019Brien SE, Proffitt C, et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res. 2011;71(4):1418\u201330.","journal-title":"Cancer Res"},{"issue":"11","key":"6588_CR21","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1021\/jm5004842","volume":"57","author":"L Colis","year":"2014","unstructured":"Colis L, Ernst G, Sanders S, Liu H, Sirajuddin P, Peltonen K, et al. Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors. J Med Chem. 2014;57(11):4950\u201361.","journal-title":"J Med Chem"},{"issue":"12","key":"6588_CR22","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.18632\/oncotarget.2020","volume":"5","author":"L Colis","year":"2014","unstructured":"Colis L, Peltonen K, Sirajuddin P, Liu H, Sanders S, Ernst G, et al. DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response. Oncotarget. 2014;5(12):4361\u20139.","journal-title":"Oncotarget"},{"issue":"1","key":"6588_CR23","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41467-021-26640-x","volume":"12","author":"M Pan","year":"2021","unstructured":"Pan M, Wright WC, Chapple RH, Zubair A, Sandhu M, Batchelder JE, et al. The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma. Nat Commun. 2021;12(1):6468.","journal-title":"Nat Commun"},{"issue":"7","key":"6588_CR24","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/biomedicines12071514","volume":"12","author":"DP Cameron","year":"2024","unstructured":"Cameron DP, Sornkom J, Alsahafi S, Drygin D, Poortinga G, Mcarthur GA, et al. CX-5461 preferentially induces Top2\u03b1-dependent DNA breaks at ribosomal DNA loci. Biomedicines. 2024;12(7):1514.","journal-title":"Biomedicines."},{"issue":"8","key":"6588_CR25","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1093\/nar\/gkae069","volume":"52","author":"JA Espinoza","year":"2024","unstructured":"Espinoza JA, Kanellis DC, Saproo S, Leal K, Martinez JF, Bartek J, et al. Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II. Nucleic Acids Res. 2024;52(8):4151\u201366.","journal-title":"Nucleic Acids Res"},{"issue":"30","key":"6588_CR26","doi-asserted-by":"publisher","first-page":"27423","DOI":"10.1074\/jbc.M201232200","volume":"277","author":"AH Cavanaugh","year":"2002","unstructured":"Cavanaugh AH, Hirschler-Laszkiewicz I, Hu Q, Dundr M, Smink T, Misteli T, et al. Rrn3 phosphorylation is a regulatory checkpoint for ribosome biogenesis. J Biol Chem. 2002;277(30):27423\u201332.","journal-title":"J Biol Chem"},{"key":"6588_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103094","volume":"91","author":"S Bhagat","year":"2019","unstructured":"Bhagat S, Arfeen M, Das G, Ramkumar M, Khan SI, Tekwani BL, et al. Design, synthesis and biological evaluation of 4-aminoquinoline-guanylthiourea derivatives as antimalarial agents. Bioorg Chem. 2019;91: 103094.","journal-title":"Bioorg Chem"},{"issue":"D1","key":"6588_CR28","doi-asserted-by":"publisher","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","volume":"50","author":"G Tang","year":"2022","unstructured":"Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2022;50(D1):D1334\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"6588_CR29","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete JT, Gyorffy B. ROCplot.org: Validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J Cancer. 2019;145(11):3140\u201351.","journal-title":"Int J Cancer"},{"key":"6588_CR30","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1038\/ncomms12129","volume":"7","author":"C Engel","year":"2016","unstructured":"Engel C, Plitzko J, Cramer P. RNA polymerase I-Rrn3 complex at 4.8 A resolution. Nat Commun. 2016;7:12129.","journal-title":"Nat Commun"},{"key":"6588_CR31","doi-asserted-by":"publisher","first-page":"1188652","DOI":"10.3389\/fbioe.2023.1188652","volume":"11","author":"S Chattopadhyay","year":"2023","unstructured":"Chattopadhyay S, Sarkar SS, Saproo S, Yadav S, Antil D, Das B, et al. Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A\u2013B1 and 34A. Front Bioeng Biotechnol. 2023;11:1188652.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"6588_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12967-024-05715-5","volume":"22","author":"SS Sarkar","year":"2024","unstructured":"Sarkar SS, Sharma M, Saproo S, Naidu S. LINC01116-dependent upregulation of RNA polymerase I transcription drives oncogenic phenotypes in lung adenocarcinoma. J Transl Med. 2024;22(1):904.","journal-title":"J Transl Med"},{"key":"6588_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","volume":"1263","author":"MY Pai","year":"2015","unstructured":"Pai MY, Lomenick B, Hwang H, Schiestl R, McBride W, Loo JA, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287\u201398.","journal-title":"Methods Mol Biol"},{"issue":"9","key":"6588_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9): e45.","journal-title":"Nucleic Acids Res"},{"key":"6588_CR35","first-page":"56450","volume":"128","author":"Y Lu","year":"2017","unstructured":"Lu Y, Liu Y, Yang C. Evaluating in vitro DNA damage using comet assay. J Vis Exp. 2017;128:56450.","journal-title":"J Vis Exp"},{"issue":"2","key":"6588_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0165-1110(81)90029-4","volume":"87","author":"MO Bradley","year":"1981","unstructured":"Bradley MO, Bhuyan B, Francis MC, Langenbach R, Peterson A, Huberman E. Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat Res. 1981;87(2):81\u2013142.","journal-title":"Mutat Res"},{"issue":"10","key":"6588_CR37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/onc.2011.319","volume":"31","author":"M Uemura","year":"2012","unstructured":"Uemura M, Zheng Q, Koh CM, Nelson WG, Yegnasubramanian S, De Marzo AM. Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation. Oncogene. 2012;31(10):1254\u201363.","journal-title":"Oncogene"},{"issue":"20","key":"6588_CR38","doi-asserted-by":"publisher","first-page":"ar3","DOI":"10.1091\/mbc.E21-05-0251","volume":"32","author":"H Liao","year":"2021","unstructured":"Liao H, Gaur A, Mauvais C, Denicourt C. p53 induces a survival transcriptional response after nucleolar stress. Mol Biol Cell. 2021;32(20):ar3.","journal-title":"Mol Biol Cell"},{"issue":"18","key":"6588_CR39","doi-asserted-by":"publisher","first-page":"8770","DOI":"10.1021\/acs.chemrev.8b00169","volume":"118","author":"N Patel","year":"2018","unstructured":"Patel N, Sood R, Bharatam PV. NL(2)(+) systems as new-generation phase-transfer catalysts. Chem Rev. 2018;118(18):8770\u201385.","journal-title":"Chem Rev"},{"issue":"24","key":"6588_CR40","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1002\/chem.201705999","volume":"24","author":"N Patel","year":"2018","unstructured":"Patel N, Arfeen M, Sood R, Khullar S, Chakraborti AK, Mandal SK, et al. Can remote N-heterocyclic carbenes coordinate with main group elements? Synthesis, structure, and quantum chemical analysis of N(+) -centered complexes. Chemistry. 2018;24(24):6418\u201325.","journal-title":"Chemistry"},{"issue":"3","key":"6588_CR41","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/chem.201503618","volume":"22","author":"PV Bharatam","year":"2016","unstructured":"Bharatam PV, Arfeen M, Patel N, Jain P, Bhatia S, Chakraborti AK, et al. Design, synthesis, and structural analysis of divalent N(I) compounds and identification of a new electron-donating ligand. Chemistry. 2016;22(3):1088\u201396.","journal-title":"Chemistry"},{"issue":"3","key":"6588_CR42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jcc.26935","volume":"44","author":"G Dubey","year":"2023","unstructured":"Dubey G, Singh T, Bharatam PV. The importance of four-membered NHCs in stabilizing Breslow intermediates on benzoin condensation pathway. J Comput Chem. 2023;44(3):346\u201354.","journal-title":"J Comput Chem"},{"issue":"36","key":"6588_CR43","doi-asserted-by":"publisher","first-page":"9071","DOI":"10.1021\/jp304789u","volume":"116","author":"S Bhatia","year":"2012","unstructured":"Bhatia S, Bagul C, Kasetti Y, Patel DS, Bharatam PV. Divalent N(I) character in 2-(thiazol-2-yl)guanidine: an electronic structure analysis. J Phys Chem A. 2012;116(36):9071\u20139.","journal-title":"J Phys Chem A"},{"issue":"4","key":"6588_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/genes12040502","volume":"12","author":"CM Harold","year":"2021","unstructured":"Harold CM, Buhagiar AF, Cheng Y, Baserga SJ. Ribosomal RNA transcription regulation in breast cancer. Genes (Basel). 2021;12(4):502.","journal-title":"Genes (Basel)"},{"issue":"11","key":"6588_CR45","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1158\/1541-7786.MCR-14-0229","volume":"12","author":"K Rothblum","year":"2014","unstructured":"Rothblum K, Hu Q, Penrod Y, Rothblum LI. Selective inhibition of rDNA transcription by a small-molecule peptide that targets the interface between RNA polymerase I and Rrn3. Mol Cancer Res. 2014;12(11):1586\u201396.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"6588_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010854","volume":"19","author":"S Dash","year":"2023","unstructured":"Dash S, Lamb MC, Lange JJ, McKinney MC, Tsuchiya D, Guo F, et al. rRNA transcription is integral to phase separation and maintenance of nucleolar structure. PLoS Genet. 2023;19(8): e1010854.","journal-title":"PLoS Genet"},{"issue":"1","key":"6588_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"6588_CR48","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41467-019-10100-8","volume":"10","author":"V Prakash","year":"2019","unstructured":"Prakash V, Carson BB, Feenstra JM, Dass RA, Sekyrova P, Hoshino A, et al. Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease. Nat Commun. 2019;10(1):2110.","journal-title":"Nat Commun"},{"issue":"23","key":"6588_CR49","doi-asserted-by":"publisher","first-page":"14672","DOI":"10.3390\/ijms232314672","volume":"23","author":"D Jurkovicova","year":"2022","unstructured":"Jurkovicova D, Neophytou CM, Gasparovic AC, Goncalves AC. DNA damage response in cancer therapy and resistance: challenges and opportunities. Int J Mol Sci. 2022;23(23):14672.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6588_CR50","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1038\/s41467-020-16393-4","volume":"11","author":"E Sanij","year":"2020","unstructured":"Sanij E, Hannan KM, Xuan J, Yan S, Ahern JE, Trigos AS, et al. CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer. Nat Commun. 2020;11(1):2641.","journal-title":"Nat Commun"},{"issue":"1","key":"6588_CR51","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41588-023-01602-9","volume":"56","author":"GCC Koh","year":"2024","unstructured":"Koh GCC, Boushaki S, Zhao SJ, Pregnall AM, Sadiyah F, Badja C, et al. The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells. Nat Genet. 2024;56(1):23\u20136.","journal-title":"Nat Genet"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06588-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06588-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06588-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:02:14Z","timestamp":1760968934000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06588-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6588"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06588-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1131"}}